{"entity":{"type":"insider","cik":"0001455318","url":"/insider/0001455318","json_url":"/insider/0001455318.json","name":"Mihalik Vincent P","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":3,"first":"2012-02-10","last":"2012-03-02","span_basis":"filed_date"},"name_variants":[{"name":"Mihalik Vincent P","source":"filing","n_filings":3,"first_seen":"2012-02-10","last_seen":"2012-03-02"}],"transactions":[{"id":3029003,"accession":"0001264124-12-000082","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001264124-12-000082","line_url":"/filing/0001264124-12-000082#line-1","is_derivative":false,"issuer_cik":"0000881464","issuer_name":"AMYLIN PHARMACEUTICALS INC","issuer_ticker":"AMLN","issuer_name_source":null,"issuer_url":"/issuer/0000881464","owner_cik":"0001455318","owner_name":"Mihalik Vincent P","owner_display_name":"Mihalik Vincent P","owner_url":"/insider/0001455318","role":"Officer (SVP, Chief Commercial Officer), Other","role_mark":"O","role_mark_label":"Officer (SVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1231.0,"shares_display":"1,231","price_per_share":17.11,"price_display":"17.11","price_state":"stated","total_value":21062.41,"total_display":"21,062.41","total_whole":"21,062","shares_owned_after":29027.0,"shares_owned_after_display":"29,027","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-03-01","filed_date":"2012-03-02","scope":"insider"},{"id":2802679,"accession":"0001264124-12-000062","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001264124-12-000062","line_url":"/filing/0001264124-12-000062#line-2","is_derivative":false,"issuer_cik":"0000881464","issuer_name":"AMYLIN PHARMACEUTICALS INC","issuer_ticker":"AMLN","issuer_name_source":null,"issuer_url":"/issuer/0000881464","owner_cik":"0001455318","owner_name":"Mihalik Vincent P","owner_display_name":"Mihalik Vincent P","owner_url":"/insider/0001455318","role":"Officer (SVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7518.0,"shares_display":"7,518","price_per_share":17.0302,"price_display":"17.03","price_state":"stated","total_value":128033.0436,"total_display":"128,033.04","total_whole":"128,033","shares_owned_after":29657.0,"shares_owned_after_display":"29,657","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-23","filed_date":"2012-02-24","scope":"insider"},{"id":3142558,"accession":"0001264124-12-000030","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001264124-12-000030","line_url":"/filing/0001264124-12-000030#line-2","is_derivative":false,"issuer_cik":"0000881464","issuer_name":"AMYLIN PHARMACEUTICALS INC","issuer_ticker":"AMLN","issuer_name_source":null,"issuer_url":"/issuer/0000881464","owner_cik":"0001455318","owner_name":"Mihalik Vincent P","owner_display_name":"Mihalik Vincent P","owner_url":"/insider/0001455318","role":"Officer (SVP, Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (SVP, Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP, Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3842.0,"shares_display":"3,842","price_per_share":16.6158,"price_display":"16.62","price_state":"stated","total_value":63837.9036,"total_display":"63,837.90","total_whole":"63,838","shares_owned_after":17175.0,"shares_owned_after_display":"17,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-02-08","filed_date":"2012-02-10","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":3,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000881464","name":"AMYLIN PHARMACEUTICALS INC","url":"/issuer/0000881464","role":"Officer (SVP, Chief Commercial Officer), Other","n_filings":3,"first_seen":"2012-02-10","last_seen":"2012-03-02"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001455318","retrieved_at":"2026-08-22T14:19:07+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}